Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

US Patent 6743441 · Granted Jun 1, 2004

Estimated economic value: $26,029,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hunting tool2023
Formulations and methods for providing progestin-only contraception while minimi2019
Compositions and methods for unoccluded transdermal oxybutynin therapy2019
Compositions and methods for unoccluded transdermal oxybutynin therapy2019
Formulations and methods for providing progestin-only contraception while minimi2018
Unoccluded topical oxybutynin gel composition and methods for transdermal oxybut2012
Unoccluded topical oxybutynin gel composition and methods for transdermal oxybut2012
Plurality of devices attached by solder bumps2010
Methods of bonding two semiconductor devices2007
Compositions and methods for transdermal oxybutynin therapy2007
Compositions and methods for transdermal oxybutynin therapy2007
Compositions and methods for minimizing adverse drug experiences associated with2006